Get started
Author

Nathaniel H. Fleming

Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patients
2014 · Nathaniel H. Fleming, Judy Zhong, et al. · Cancer · 104
PDF
Analysis of Recurrence Patterns in Acral Versus Nonacral Melanoma: Should Histologic Subtype Influence Treatment Guidelines?
2014 · Priyanka V. Gumaste, Nathaniel H. Fleming, et al. · Journal of the National Comprehensive Cancer Network · 51
PDF
Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins
2018 · Caroline C. Kim, Elizabeth G. Berry, et al. · JAMA Dermatology · 49
PDF
Reexamining the Threshold for Reexcision of Histologically Transected Dysplastic Nevi
2016 · Nathaniel H. Fleming, Barbara M. Egbert, et al. · JAMA Dermatology · 41
PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition
2013 · Heidi L. Gold, Jordan Wengrod, et al. · Molecular Cancer Research · 35
Clinicopathological characteristics at primary melanoma diagnosis as risk factors for brain metastasis
2013 · Meng Qian, Michelle W. Ma, et al. · Melanoma Research · 30
Impact of primary care provider density on detection and diagnosis of cutaneous melanoma
2018 · Nathaniel H. Fleming, Madeline M. Grade, et al. · PLoS ONE · 23
PDF
TERT, BRAF, and NRAS Mutational Heterogeneity between Paired Primary and Metastatic Melanoma Tumors
2020 · Gregory A. Chang, Jennifer M. Wiggins, et al. · Journal of Investigative Dermatology · 22
PDF
Impact of Age on the Management of Primary Melanoma Patients
2013 · Nathaniel H. Fleming, Jiaying Tian, et al. · Oncology · 19
PDF
Genetic associations of the interleukin locus at 1q32.1 with clinical outcomes of cutaneous melanoma
2015 · Justin Rendleman, Matjaz Vogelsang, et al. · Journal of Medical Genetics · 17
PDF
Outcomes of surgical re-excision versus observation of severely dysplastic nevi: A single-institution, retrospective cohort study
2019 · Nathaniel H. Fleming, Amanda R. Shaub, et al. · Journal of the American Academy of Dermatology · 15
PDF
Classification and Management of Ischemic Stroke in Patients With Active Cancer: A Scientific Statement From the American Heart Association
2026 · Babak B. Navi, Scott E. Kasner, et al. · Stroke · 10
Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients
2012 · Erica B. Friedman, Shulian Shang, et al. · Journal of Biomedical Science and Engineering · 7
PDF
Risk of dementia in older veterans with multiple sclerosis
2023 · Nathaniel H Fleming, Amber Bahorik, et al. · Multiple Sclerosis and Related Disorders · 5
PDF
Genetic variation in immunomodulatory genes as markers of melanoma recurrence-free and overall survival.
2013 · Justin Rendleman, Shulian Shang, et al. · Journal of Clinical Oncology · 3
Il10 Locus As a Biomarker of Melanoma Survival
2014 · J. Rendleman, C. Adaniel, et al. · Annals of Oncology · 1
Analysis of recurrence patterns in acral versus non-acral melanoma: Should histologic subtype influence treatment guidelines?
2014 · Priyanka Gumaste, Nathaniel H. Fleming, et al. · Journal of Clinical Oncology · 1
Circulating tumor cells (CTCs) and association with survival in molecular subtypes (MST) of metastatic breast cancer (MBC).
2010 · M. Graham, N. Fleming, et al. · Journal of Clinical Oncology · 1
Social Determinants of Health in Early to Mid-Adulthood and Risk of Early-Onset Stroke
2026 · Nathaniel Fleming, Christina Dintica, et al. · Stroke
The Association Between Social Determinants of Health and Alzheimer Disease Blood Biomarkers in Midlife
2026 · Christina S. Dintica, Gargi Porwal, et al. · medRxiv
Characteristics of Low-Volume Stroke Thrombectomy Centers in Florida (P10-13.019)
2025 · Nathaniel Fleming, Liza Solovey, et al. · Neurology
Abstract WP101: Rural-Urban Differences in Whether Stroke Thrombectomy is Performed at the Nearest or More Distant Thrombectomy-Capable Centers in Florida
2025 · Nathaniel Fleming, Liza Solovey, et al. · Stroke
Chapter 9: Sleep Medicine
2023 · Nathaniel H. Fleming, Liza Ashbrook · Neurology
PDF
Supplementary Tables 1 - 5 from PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition
2023 · Heidi L. Gold, Jordan Wengrod, et al.
Supplementary Tables 1 - 5 from PP6C Hotspot Mutations in Melanoma Display Sensitivity to Aurora Kinase Inhibition
2023 · Heidi L. Gold, Jordan Wengrod, et al.
PDF
Works count: 42
Citation count: 434
H-index: 11
I10-index: 12
Year
Topic
Type